Drug treatment and formation of eicosanoids in patients with chronic inflammatory bowel disease.
Lauritsen
K
K
Department of Medical Gastroenterology, Odense University Hospital, Denmark.
D000636:Aminosalicylic Acids / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000188:drug therapy / Q000378:metabolism; D003424:Crohn Disease / Q000188:drug therapy / Q000378:metabolism; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy* / Q000378:metabolism; D007975:Leukotriene B4 / Q000096:biosynthesis*; D019804:Mesalamine; D011453:Prostaglandins / Q000096:biosynthesis*; D012460:Sulfasalazine / Q000627:therapeutic use*; D013929:Thromboxane B2 / Q000096:biosynthesis
D000636:Aminosalicylic Acids; D011453:Prostaglandins; D007975:Leukotriene B4; D012460:Sulfasalazine; D019804:Mesalamine; D013929:Thromboxane B2; C032587:olsalazine